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EXECUTIVE SUMMARY 
Aims: Dysfunction in inhibitory and error-evaluation systems has been highlighted in theories of the 
development and maintenance of addiction, but the evidence suggests the dysfunction differs by 
drug. Specifically, among cannabis users, the literature presents an inconsistent view of behavioural 
measures in support of such deficits; underlying alcohol use, which has also been linked with self-
regulation problems, may explain these differences. We report a novel study examining inhibitory 
control in young regular cannabis users and extend on past research by controlling for alcohol use 
and including measurement of event-related potentials (ERPs). 
 
Methods: 20 regular cannabis users and 74 non-users (aged 18-21 years) completed a stop-signal 
task while brain electrical activity was recorded. Post-experimentally, propensity weighting accounted 
for group differences in alcohol use. Measures include the time required to stop a response (stop-
signal reaction time or SSRT), N2 and P3 amplitude and latency to stop-signals on which inhibition 
failed vs. was successful, and the error-related negativity and positivity (ERN and Pe, respectively) to 
erroneous responses. 
 
Results: Cannabis users and non-users did not differ on SSRT, or reaction time or accuracy to Go-
only trials. The groups also did not differ on ERN or Pe amplitude or latency, on N2 or P3 latency for 
successful or failed inhibitions, or on N2 or P3 amplitude to successful inhibitions. However, the 
cannabis user group displayed increased N2 amplitude, and decreased P3 amplitude, on failed 
inhibition trials, relative to non-users. 
 
Discussion: Together, the results suggest intact inhibitory processing and error monitoring, but 
changes in conflict monitoring processes among young regular cannabis users. Limitations of the 
study are discussed, including the group differences in alcohol consumption, the heaviness of 
cannabis use, and the possibility of acute cannabis intoxication effects. Future research confirming 
conflict monitoring deficits among young cannabis users is indicated. 
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1. INTRODUCTION 
Recent models of the development and maintenance of substance abuse implicate deficient 
inhibitory control over overt behaviours (Hester et al., 2010, Goldstein and Volkow, 2002), and 
indeed difficulties with controlling behaviour are implicated in DSM-5 criteria for substance 
abuse including repeated failed efforts to reduce use, and using more or more often than 
intended (American Psychiatric Association, 2013). Although an inhibitory deficit appears to 
be common across users of several categories of substances (Smith et al., 2014), for 
cannabis the evidence is mixed. In this study we focus on inhibition using the stop-signal 
paradigm (Logan et al., 1984), which requires participants to press a left or right hand button 
in response to a primary ‘Go’ stimulus (e.g., a leftward or rightward arrow), and inhibit that 
response when an occasional stop-signal (e.g., an auditory tone) is presented. The delay 
between the Go and stop-signal stimuli is varied to observe a participant’s probability of 
inhibition at different delays. The result is an inhibition function from which one can estimate 
the time it takes the inhibitory process to stop a response, also known as the ‘stop-signal 
reaction time’ (SSRT). In healthy control adults, typical SSRT is around 200-250ms (Band et 
al., 2003); SSRT is significantly longer in users of cocaine, methamphetamine, and alcohol 
(Smith et al., 2014). However, despite some studies reporting significantly longer SSRT 
among cannabis users (Moreno et al., 2012), or with a medium-large effect size which 
approaches statistical significance (Lovell et al., 2018), the majority of studies report only 
small/non-significant differences in SSRT between cannabis users and their assorted control 
groups (Ramaekers et al., 2009, Theunissen et al., 2012, Jutras-Aswad et al., 2012, Huddy et 
al., 2013, Grant et al., 2012, Filbey and Yezhuvath, 2013). 
 
Apart from variations between studies in the extent of participants’ cannabis use, a possible 
factor underlying the inconsistent evidence for an inhibitory deficit may be the extent of 
alcohol use in participants; heavy drinking is itself associated with a small inhibitory deficit 
(Smith et al., 2014). Since the majority of cannabis users also drink alcohol (Australian 
Institute of Health and Welfare, 2011), it is important to assess and control for the level of 
alcohol consumption in both cannabis-using and non-using control groups. In this study, we 
will improve on prior research into possible inhibitory deficits associated with recreational 
cannabis use by taking into account the confounding effects of alcohol use. 
 
We included both behavioural and brain functional measures of response inhibition to 
examine this effect. Specifically, we measured event-related potentials (ERPs), the brain’s 
average electrical response to an event, measured non-invasively from the scalp. Brain 
functional measures can be more sensitive to deficits than behavioural measures alone 
(Mahmood et al., 2013, Tarter et al., 2003, Norman et al., 2011, Luijten et al., 2016), and 
because characteristic peaks and troughs of the ERP waveform have been linked with 
specific stages of processing, ERPs can highlight which processes differ or are intact. In 
contrast, behavioural measures such as accuracy or reaction time index only the final 
outcome of the processing stream. The ERP components most commonly examined in 
response to stop-signal stimuli are the N2 and P3 components, compared on trials where 
inhibition was successful (i.e., no response was made) and when inhibition fails to stop the 
response. The N2 is a negative-going component peaking 150-300ms post-stop-signal, while 
the P3 is a positive-going component peaking around 250-400ms post-stop-signal. The N2 is 
typically larger on failed inhibition trials, and thus is thought to represent error-related activity 
(Dimoska et al., 2006) or response conflict monitoring (Kok et al., 2004); the P3 is typically 
larger on successful inhibition trials, and thus is thought to represent the active cancellation of 
the motor response (Kok et al., 2004). ERPs are also examined time-locked to responses, 
with a difference wave calculated for erroneous responses (i.e., trials where inhibition failed) 
versus correct responses (i.e., on Go trials for which no stop-signal is delivered). ERP 
components examined include the error-related negativity (ERN) and error positivity (Pe). The 
ERN typically peaks in the first 100ms after an error, and indexes unconscious error 
detection, while the Pe is a slow wave occurring around 300-500ms post-error and indexes 
conscious error detection (Falkenstein et al., 1990, Falkenstein et al., 2000, Nieuwenhuis et 
al., 2001, Simons, 2010). 
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Only one study (Theunissen et al., 2012) has examined ERPs in the stop-signal task in 12 
heavy cannabis users (smoking more than four times per week) vs. 12 occasional cannabis 
users (once a week or less; the minimum use was not specified). Groups were matched for 
tobacco and alcohol use, as well as duration and heaviness of cannabis use (that is, they 
differed on frequency of use only). The researchers found no group differences in the 
amplitude of N2 to stop-signals on successful inhibition trials, or to Go signals; they did not 
measure N2 on failed inhibition trials, nor any other ERP component. 
 
In the current study, we extend the literature by not only reporting data from a larger sample, 
but with careful statistical approaches accounting for differences in alcohol use, and with a 
greater range of ERP components measured, indexing a wider range of psychological 
processes. 
 
2. METHODS 
2.1 Participants 
Participants were 94 young adults (aged 18-21 years) recruited from the University of New 
South Wales. They were recruited into two groups: Cannabis Users (9 female, 11 male) who 
reported using cannabis at least twice per month for at least the last 12 months, and Controls 
(33 female, 41 male) who reported using cannabis less often than this (including never). 
Cannabis Users were mostly also heavy drinkers (85% consumed 4 or more standard drinks 
at least once a month); data from non-cannabis-using Controls (reported in Smith et al., 2016) 
also varied on their lifetime alcohol consumption, such that 50% reported episodic heavy 
drinking. Participants were recruited from posters displayed on the university campus, via an 
online paid research participation system, and via participant referral. They were excluded if 
they had ever had an epileptic seizure, a serious head injury or period of unconsciousness, 
uncorrected hearing or vision problems, or regular (twice a month) use of other drugs except 
tobacco (including illicit drugs, and prescription drugs used outside the reason or dose for 
which they were prescribed). Additionally, participants reported no use of psychoactive 
medication. All participants gave written informed consent, and the UNSW Human Research 
Ethics Committee approved the protocol before data collection began. Participants completed 
a single 2 hour laboratory session, and were thanked for their time and effort with a $20 
iTunes voucher and $10 cash. 
2.2 Measures  
Participants completed a brief demographic questionnaire, followed by the Alcohol Use 
Disorders Identification Test (Saunders et al., 1993). The third question of the AUDIT was 
changed to “How often do you have four or more standard drinks?” to reflect Australian 
alcohol consumption guidelines (National Health and Medical Research Council, 2009). 
Participants next completed the Drug Use Disorders Identification Test – Extended (DUDIT-E, 
Berman et al., 2007), which assesses the frequency of use of a range of drug classes other 
than alcohol; tobacco use is assessed but does not contribute to the total score. The reported 
frequency of cannabis use was used to group participants. Participants then underwent 
structured interviews assessing lifetime alcohol use and lifetime cannabis use using modified 
versions of the Lifetime Drinking History interview (Skinner, 1977). This records the frequency 
and quantity of consumption in relatively homogenous phases from the onset of regular 
drinking (one standard drink per month) or regular cannabis use (one use occasion per 
month), and can be used to estimate the number of standard drinks consumed in the 
participant’s lifetime, the age of first regular use of cannabis, and the frequency of cannabis 
use in the last 6 months. Participants were required to reference a standard drinks guide 
while they completed the AUDIT and the alcohol lifetime history. 
2.3 Stop-signal task 
The stop-signal task used has been described previously in Smith et al. (2016). Go stimuli 
were green leftward and rightward arrows appearing above a grey central fixation cross on a 
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black background. Go stimuli were presented for 1000ms with a mean SOA of 1500ms (1200-
1800ms). Participants were instructed to press the ‘S’ or ‘L’ button on a standard QWERTY 
keyboard with their left or right index finger, respectively, according to the direction of the 
arrow. On a random 25% of trials, a 1500Hz pure tone lasting 200ms with 20ms rise and fall 
time was presented binaurally through headphones; this stop-signal indicated to participants 
that they must inhibit their response. Participants completed a 10 trial practice block with only 
Go signals, followed by a 40 trial practice block with 10 stop-signal trials set at post-Go-
stimulus delays of 100ms, 200ms, 300ms, 400ms and 500ms (2 at each delay). Participants 
then completed 4 experimental blocks of 120 trials each. Mean reaction time (MRT) to the Go 
stimulus on trials where no stop-signal was presented was calculated for the second practice 
block and first three experimental blocks, and used to set delays in the subsequent block. In 
the experimental blocks, stop-signals were delivered at set intervals before MRT from the 
previous block (MRT-450, MRT-350, MRT-250, MRT-150, and MRT-50ms) (Logan et al., 
1984, Logan, 1994). This method counteracts strategic slowing (i.e., slowing of Go responses 
in order to increase the probability of successful inhibition) by delaying stop-signals by an 
equivalent amount in the following block, so that the probability of inhibition is relatively 
constant over blocks. Where the MRT – x formula would result in a negative number, the 
stop-signal was delivered at 0ms instead. Further, if the participant did not respond within 
1000ms, the words “TOO SLOW” were displayed for 500ms after the Go stimulus, and 
participants were advised to avoid this. 
2.4 Electrophysiological recording 
Continuous monopolar EEG was recorded from 58 scalp sites using an elasticised cap with 
tin electrodes. Additional tin cup electrodes recorded activity from the left and right mastoid as 
well as vertical and horizontal EOG. All electrodes were referenced to an electrode on the tip 
of the nose, rounded midway between Fpz and Fz. Electrode impedances were below 5 kΩ. 
Signals were recorded DC to 200 Hz, amplified 10 times, and sampled at 1000 Hz using 
Neuroscan recording software and hardware (Synamps 2). 
2.5 Data analysis 
Due to some participants responding very quickly in the second practice block, poor inhibitory 
performance and very long SSRTs were displayed for the first experimental block for these 
participants. Therefore, behavioural analyses use only data from the last three experimental 
blocks, while ERP analyses use data from all four blocks. 
 
For each participant, in addition to calculating MRT and accuracy to Go stimuli on trials where 
no stop signal was delivered, we calculated the probability of successfully inhibiting a 
response where a stop-signal was delivered (adjusted for omission errors: Tannock et al., 
1995), and estimated the SSRT (Logan, 1994). The averages were calculated across blocks. 
 
Offline, using Neuroscan software, the EEG was re-referenced to linked mastoids, bandpass 
filtered between 0.1 Hz (down 12 dB/octave) and 30 Hz (down 48 dB/octave, zero phase 
shift) and corrected for vertical eye movements and blinks (Semlitsch et al., 1986). ERPs to 
the stop-signal were created by epoching from 100ms before to 900ms after the onset of the 
stop-signal, baseline correcting to the prestimulus interval, rejecting trials with amplitude 
outside ±100µV, and separately averaging successful and failed inhibition trials. A minimum 
18 trials were included in these averages; Controls had more successful inhibitions (SI) and 
fewer failed inhibitions (FI) than Cannabis Users (Controls SI = 59, Cannabis Users SI = 53, 
F(1,92) = 3.380, p = 0.069; Controls FI = 45, Cannabis Users FI = 53, F(1,92) = 4.949, p = 
0.029). The N2 was detected in these waveforms as the minimum amplitude in the 200-
400ms window at FCz, while the P3 was the maximum amplitude in the 350-550ms window at 
FCz; baseline-to-peak amplitude measurements were made at this latency at all sites to allow 
topographic mapping (Picton et al., 2000). Error-related ERPs were created by epoching from 
500ms before to 500ms after a response, baseline correcting to the pre-response interval, 
rejecting trials with amplitude outside ±100µV, separately averaging correct and incorrect 
responses, and then subtracting the correct waveform from the incorrect waveform to 
calculate error-related response processing (e.g., Falkenstein et al., 1990). A minimum 280 
correct trials, and a minimum 19 incorrect trials were included for averaging; there were no 
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group differences in the average number of correct trials accepted (Controls correct = 404, 
Cannabis Users correct = 413, F(1,92) = 2.292, p = 0.134). In contrast, and mirroring 
behavioural results, Cannabis Users had more incorrect trials accepted (Controls incorrect = 
46, Cannabis Users incorrect = 54, F(1,92) = 5.425, p = 0.022). The ERN was detected in the 
difference waveform as the minimum amplitude in the 0-150ms window at FCz, and the Pe as 
the maximum amplitude in the window 200-450ms at CPz, and baseline-to-peak amplitude 
measurements were made at this latency at all sites to allow topographic mapping. 
2.6 Statistical analysis 
Analysis was conducted using a propensity-weighted approach. Propensity weighting involves 
estimating the probability of exposure, and then weighting the outcome models by the inverse 
of that probability. This creates a pseudo-population in which the confounders are balanced 
over the exposure variable (Hirano et al., 2003, Imbens, 2004). 
 
We estimated the propensity score using a Generalized Boosted Model (GBM). GBM is a 
machine learning technique able to estimate the functional form of the relationship covariates 
and outcome with less bias than traditional approaches (McCaffrey et al., 2004). In this case, 
weights were estimated using the “twang” package in R 3.4.1 (R Development Core Team, 
2017), controlling for the covariates: age, sex, handedness, AUDIT score, lifetime alcohol 
exposure, DUDIT-E score excluding cannabis, and age of onset of regular alcohol 
consumption. Balance between the cannabis exposed and non-exposed groups was 
assessed using the absolute standard difference of the weighted and unweighted samples 
(Ridgeway et al., 2010).  
 
The effect of cannabis exposure was then estimated on a range of outcomes, using weighted 
linear regression. Models were estimated using generalised linear models for the outcomes: 
percentage correct responses to Go-only trials, MRT in ms to Go-only trials, SSRT in ms, 
amplitude of ERN at site FCz, amplitude of Pe at site CPz, latency of the ERN peak, and 
latency of the Pe peak. The remaining outcomes (probability of inhibition for stop-signals 
delivered at each delay, amplitude of N2 and P3 at site FCz, and latency of the N2 and P3 
peaks) involved multiple measurements per participant, and as such were estimated using 
weighted generalised estimating equations to control for the lack of independence between 
observations. To increase robustness, all covariates from the propensity model were also 
included in the outcome model (Bang and Robins, 2005). Thus, statistics are based on means 
controlling for the effects of other covariates, some of which alter the mean considerably. This 
is because some of the covariates included in the propensity weighting model are strongly 
related to dependent variables but not cannabis use, and adjust the means substantially. For 
example, handedness is strongly related to Go RT (mean for left handers = 467ms; for right-
handed = 515ms) but not cannabis use; when handedness is controlled for, the propensity 
weighted Go RT is substantially longer compared to the means in the unweighted model. For 
comparison with previous research, we plot unweighted means in Figures, but stress that 
statistics were based on the coefficients (as the difference between means in the units in 
which each variable was measured), and its associated standard error, provided in the text. 
 
3. RESULTS  
3.1 Demographics and balance diagnostics 
Table 1 shows the characteristics of the samples before propensity weighting. Differences in 
alcohol consumption in particular justify the use of propensity weighting. 
 
The weighted population showed greater balance over covariates than the unweighted 
population, as shown in Figure 1. However, significant imbalance remained, suggesting 
residual confounding by unmeasured confounders. 
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Table 1: Demographics of the sample for Cannabis Users and Controls (before 
propensity weighting). 
 Cannabis Users (n = 20) Controls (n = 74) 
 Mean SD Mean SD 
Sex ratio (F:M) 9:11  33:41  
Age (years) 20.3 1.2 20.0 1.2 
% right-handed 85  88  
AUDIT 10.5 4.6 6.2 4.3 
Lifetime standard drinks (log units) 2.9 0.4 2.1 1.0 
Lifetime standard drinks (mean, CI) 822.0 528.0 – 1279.6 115.9 68.8 – 195.0 
Age of onset of regular drinking 16.5 1.1 17.8 1.6 
DUDIT-E score 7.2 3.0 1.3 1.7 
DUDIT-E non-cannabis score^ 3.5 2.9 0.7 1.2 
Age first regular cannabis use* 17.2 1.2   
Frequency of cannabis use 
(days/month), last six months, median 
and range* 
8.8 1.8-30   
^ DUDIT-E non-cannabis use: this is a measure calculated from the frequency of use of non-
cannabis drugs, and is calculated as the total DUDIT-E score minus the cannabis use 
frequency score. 
* Data not recorded for the first three participants, n = 17. 
 
 
Figure 1. Absolute standard difference between groups in unweighted and propensity-
weighted scores. 
 
3.3 Behavioural performance 
Figure 2 shows unweighted performance means for each group. Cannabis Users showed 
similar accuracy on Go trials as Controls (weighted coefficient = -0.23%, SE = 0.44, p = 
0.610). For Go RT (right panels), despite an apparent difference between groups indicated in 
unweighted means, in the propensity-weighted model, Cannabis Users showed similar Go RT 
to Controls (weighted coefficient = 5.78ms, SE = 25.95, p = 0.824, bottom right panel). For 
Controls, the probability of inhibition was reduced for all delays relative to the MRT-450ms 
delay (see Figure 2, left panel, all p < 0.001); at the MRT-450 delay, the probability of 
inhibition was not significantly different between Cannabis Users and Controls in the 
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propensity-weighted model (coefficient = -3.08%, SE = 3.87, p = 0.426). Cannabis Users 
showed similar decreases in successful inhibition with increasing stop-signal delays (all p ≤ 
0.002). Further, SSRT was slightly but not significantly longer for Cannabis Users in the 
weighted model (coefficient = 4.61ms, SE = 11.33, p = 0.685; right panel). 
 
 
Figure 2. Left panel: unweighted mean response accuracy to Go and Stop-signal stimuli. 
Right panel: unweighted mean reaction time to Go stimuli, and stop-signal reaction time to 
stop-signal stimuli. Error bars represent standard errors. 
3.4 Event-related potential data 
Figures 3a and 3b show grand mean (unweighted) ERPs for each group for successful and 
failed inhibition trials; while Figures 3c-f show unweighted N2 and P3 amplitude and latency 
for each group. Figure 4 shows topographic plots of activity for each condition and group 
(unweighted).  
 
 
Figure 3. Grand mean unweighted ERPs for successful inhibitions (SI) and failed inhibitions 
(FI) at FCz, for Controls and Cannabis Users (a), and unweighted amplitude (b) and latency 
(c) of the N2 and P3 peaks for Controls (black circles) and Cannabis Users (white triangles). 
Error bars represent the standard error. 
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For the N2, failed inhibition was associated with a larger (more negative) N2 than successful 
inhibition trials in Controls (coefficient = 6.48µV, SE = 0.67, p < 0.001; see Figure 3b). 
Cannabis use was associated with a larger N2 amplitude relative to Controls for failed 
inhibition trials (coefficient = -4.79µV, SE = 2.15, p = 0.026), but not successful inhibition trials 
(coefficient = 3.46µV, SE = 2.13, p = 0.104). 
 
Among controls, successful inhibition produced a larger P3 amplitude than failed inhibition 
(coefficient = 3.46µV, SE = 0.74, p < 0.001; see Figure 3b). For failed inhibition trials, 
Cannabis Users showed a reduction in P3 amplitude relative to Controls (coefficient = -
4.57µV, SE = 1.67. p = 0.006). For successful trials, Cannabis Users produced similar P3 
amplitude compared to Controls (coefficient = 2.88µV, SE = 1.56, p = 0.064). 
 
Similar mean N2 latency was observed for successful and failed inhibition trials among 
Controls (coefficient = 3.51ms, SE = 3.69, p = 0.342; see Figure 3c), and for Controls and 
Cannabis Users for failed inhibition trials (coefficient = -2.87ms, SE = 9.88, p = 0.771) and 
successful inhibition trials (coefficient = 5.74ms, SE = 8.73, p = 0.511). 
 
For P3 latency, among Controls, successful inhibition was associated with a marginally earlier 
P3 peak than failed inhibitions (coefficient = -5.97ms, SE = 3.19, p = 0.061; see Figure 3c). 
For both failed and successful inhibition trials, the P3 peaked slightly but not significantly later 
for Cannabis Users than Controls (FI trials: coefficient = 8.21ms, SE = 8.85, p = 0.354; SI 
trials: coefficient = 9.32ms, SE = 1.81, p = 0.179). 
 
 
 
Figure 4. Topographic maps of (unweighted) activity for each component and group. All maps 
have the same scale (i.e., with 2 µV steps between adjacent shades). 
 
Figure 5 shows grand mean unweighted response-locked ERPs for each group for correct 
and incorrect responses, and their subtraction, showing the ERN and Pe. In the propensity-
weighted model, neither the amplitude of ERN nor Pe differed between groups (coefficient = -
0.78µV, SE = 1.00, p = 0.440, and coefficient = 0.43µV, SE = 1.30, p = 0.739, respectively), 
nor did the latency of ERN or Pe (coefficient = -1.07ms, SE = 8.72, p = 0.902, and coefficient 
= 25.31ms, SE = 15.78, p = 0.112, respectively). 
4. DISCUSSION 
Inhibition of inappropriate behaviours is a key aspect of executive function, and difficulties 
with this process have attracted growing interest as a contributor to the development and 
maintenance of addiction. In this study, we assessed inhibitory function in young regular 
recreational Cannabis Users relative to non-using Controls, after accounting for the extent of 
alcohol use, which is itself associated with a small deficit in inhibitory control (Smith et al., 
2014). We included not only behavioural but also brain functional measures of inhibitory 
control and error processing, and in comparison to previous research with brain functional 
measures (Theunissen et al., 2012), included a broader range of components in our analysis 
(N2 and P3 to failed and successful inhibition trials, as well as the ERN and Pe error-related 
components). 
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Figure 5. Left and middle: Grand mean unweighted correct, incorrect and difference (incorrect 
– correct) ERPs for Controls (left) and Cannabis Users (middle) at (a) FCz, at which the ERN 
was measured, and (b) CPz, at which the Pe was measured. Right column: mean ERN (top) 
and Pe (bottom) amplitude and latency for each group. Error bars represent the standard 
error; Controls represented by black circles, Cannabis Users by white triangles). 
 
 
The young recreational cannabis user sample was generally appropriate for the research 
question. Although they were not particularly heavy users, they are representative of typical 
cannabis users of this age. The Australian Institute of Health and Welfare indicates that, 
among 18-29 year olds who have used cannabis in the past year, about 30% have used once 
a week or more, and a further 15% use approximately once a month (Australian Institute of 
Health and Welfare, 2011). Similarly, the cannabis user group indicated greater 
experimentation with other illicit drugs (as indicated by the DUDIT-E non-cannabis score); this 
is somewhat to be expected since illicit drug users are often polydrug users (European 
Monitoring Centre on Drugs and Drug Addiction, 2002, Australian Institute of Health and 
Welfare, 2011). However, we confirm that regular use (twice a month or more) of other drugs 
was an exclusion criterion. The propensity weighting approach was justified due to the 
substantial differences between cannabis user and non-user groups in lifetime alcohol 
consumption, AUDIT score, and age of onset of regular drinking; the aim of propensity 
weighting is balancing these confounding variables over Cannabis User and non-using 
Control groups (Hirano et al., 2003, Imbens, 2004). 
 
We observed no cannabis-related difference in any behavioural response or inhibition 
measure: Go accuracy, Go RT, probability of inhibition and SSRT were all non-significantly 
different for Cannabis Users and Controls. This lack of a cannabis-related inhibitory difference 
is in agreement with the majority of the previously published literature (Ramaekers et al., 
2009, Theunissen et al., 2012, Jutras-Aswad et al., 2012, Huddy et al., 2013, Grant et al., 
2012, Filbey and Yezhuvath, 2013; but see also Moreno et al., 2012, Lovell et al., 2018), and 
indeed with studies of cannabis users performing a different inhibitory task (Quednow et al., 
2007, Hester et al., 2009, Pope et al., 2001, Tamm et al., 2013, Tapert et al., 2007, Takagi et 
al., 2011, Rasmussen et al., 2016, Nicholls et al., 2015, Maij et al., 2017; but see Moreno et 
al., 2012). 
 
Extending the previously published literature, we also considered a broad range of ERP 
components. Our significant results included larger N2 and smaller P3 amplitude for Cannabis 
Users relative to Controls on failed inhibition trials. These are novel results not previously 
reported in the literature. However, we observed no significant group differences in N2 or P3 
amplitude or latency on successful inhibition trials, and no differences in N2 or P3 latency on 
failed inhibition trials. Our examination of the error-related ERN and Pe components also 
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returned no group differences. We note that the lack of error-related processing differences 
on failed inhibition trials has previously been reported in other inhibitory tasks using ERPs 
(Maij et al., 2017) and functional magnetic resonance imaging (fMRI, Hester et al., 2009). 
Further, our lack of group difference in successful inhibition N2 amplitude replicates 
Theunissen et al. (2012), and is in line with Filbey et al.’s (2013) fMRI study, where they 
observed no cannabis-related differences in brain activation during successful response 
inhibition in a stop-signal task. However, other studies examining successful inhibition in 
different inhibitory tasks have reported cannabis-related differences in N2 amplitude (Nicholls 
et al., 2015), or no difference in N2 amplitude but reduced P3 amplitude in cannabis users 
(Maij et al., 2017). Further, in fMRI studies, successful inhibition has been associated with 
increased cannabis-related activation in a range of brain regions including the anterior 
cingulate cortex, putamen, right inferior parietal lobe, right hippocampus and cerebellar 
vermis, all in the context of no difference in behavioural performance (Tapert et al., 2007, 
Hester et al., 2009, Rasmussen et al., 2016), typically interpreted as the greater employment 
of these processes to display similar behavioural performance. 
 
It is possible that differences in results between studies are due to the type of inhibitory task 
employed: the “Go/NoGo” task used in those studies requires a less-urgent form of motor 
inhibition involving the withholding of a prepared response that has not yet been initiated – 
compared to the active cancellation of a motor response that has already been initiated in the 
stop-signal task (Wright et al., 2014, Barkley, 1997). Entangled with this are the specific trial-
type comparisons typically made with each task. In the stop-signal task, brain activity is often 
time-locked to stop-signals and compared on trials where inhibition fails or is successful, while 
in the Go/NoGo task, brain activity is time-locked to Go (response execution) and NoGo 
(response inhibition) stimuli, and trials where inhibition is successful are simply compared with 
Go trials. The probability of failed inhibitions is low in the Go/NoGo task, providing too few 
trials for a reliable analysis.  
 
It is unclear at this stage what is indicated by the larger N2 and reduced P3 amplitude for 
cannabis users, localised to failed inhibition trials, in the absence of differences in ERN and 
Pe. Kok et al (2004) theorised that stop-signals on such trials provide performance feedback 
to the participant that activates evaluative processes. Perhaps these evaluative processes are 
unrelated to the error-related processes elicited to the execution of an erroneous response, 
the latter of which do not appear to be impaired in cannabis users (Maij et al., 2017). An 
alternative interpretation of the N2 component in such tasks is that it reflects the detection of 
response conflict (e.g., Nieuwenhuis et al., 2003), whereby the presentation of a stop-signal 
elicits a response conflict monitoring process that causes participants to adjust performance 
on a trial by trial basis (van den Wildenberg et al., 2002). Greater N2 amplitude and reduced 
P3 amplitude by cannabis users may reflect increased efforts and/or a regulatory problem 
when employing this mechanism. 
 
The limitations of the current study are that, while the propensity weighting approach had 
some success in balancing the groups for alcohol use, some differences remained; the 
alcohol variables included in our propensity weighting do not explain much variance in terms 
of cannabis user vs. non-user group membership, and a wider range of variables could be 
included in future efforts using this method. Alternately, the groups could be more carefully 
matched for alcohol use at the outset, possibly with recruitment of heavier users (assuming 
that any effects are dose-dependent), and with participants who were naïve to any other illicit 
drugs. Lastly, we know that acute cannabis intoxication strongly affects SSRT (Theunissen et 
al., 2012) and error processing (Kowal et al., 2015) but we did not assess intoxication levels 
either by self-report (e.g., time/date of last use) or by objective measures (e.g., saliva, blood 
or urine tests); future research should include these measures in order to rule out acute 
intoxication effects.  
5. CONCLUSIONS 
In summary, we found that when alcohol use is controlled as a confounding factor, cannabis 
users appear capable of triggering the inhibitory control process as effectively as non-users, 
and they do not differ in neural processes following the making of an erroneous response. 
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Our results have replicated the findings of previous studies, and go further to suggest 
previously-detected significant results in this area may have been confounded by alcohol use 
in participants. However, it is clear that there are some differences between cannabis users 
and non-users at an electrophysiological level occurring on trials when they fail to effectively 
inhibit a response and this warrants further investigation. The extension of our approach to 
the current literature, which mostly examines only behavioural indices of inhibitory control in 
this population group, highlights the need to focus research efforts on underlying neural 
processes. 
14 
6. REFERENCES 
American Psychiatric Association, 2013. DSM-5. Diagnostic and Statistical Manual of Mental 
Disorders, 5th edition, Arlington, VA, American Psychiatric Publishing. 
Australian Institute of Health and Welfare, 2011. 2010 National Drug Strategy Household 
Survey report. Canberra: Australian Institute of Health and Welfare. 
Band, G. P. H., Van der Molen, M. W. & Logan, G. D. 2003. Horse-race model simulations of 
the stop-signal procedure. Acta Psychologica, 112, 105-142. 
Bang, H. & Robins, J. M. 2005. Doubly robust estimation in missing data and causal inference 
models. Biometrics, 61, 962-972. 
Barkley, R. A. 1997. Behavioural inhibition, sustained attention, and executive functions: 
constructing a unifying theory of ADHD. Psychological Bulletin, 121, 65-94. 
Berman, A. H., Palmstierna, T., Källmén, H. & Bergman, H. 2007. The self-report Drug Use 
Disorders Identification Test—Extended (DUDIT-E): Reliability, validity, and 
motivational index. Journal of Substance Abuse Treatment, 32, 357-369. 
Dimoska, A., Johnstone, S. J. & Barry, R. J. 2006. The auditory-evoked N2 and P3 
components in the stop-signal task: Indices of inhibition, response-conflict or error-
detection? Brain and Cognition, 62, 98-112. 
European Monitoring Centre for Drugs and Drug Addiction, D. 2002. 2002 Annual Report on 
the state of the drugs problem in the European Union and Norway, Luxembourg, 
Office for Official Publications of the European Communities. 
Falkenstein, M., Hohnsbein, J., Hoormann, J. & Blanke, L. 1990. Effects of errors in choice 
reaction tasks on the ERP under focused and divided attention. In: BRUNIA, C. H. M., 
GAILLARD, A. W. K. & KOK, A. (eds.) Psychophysiological Brain Research. Tilburg: 
Tilburg Univesity Press. 
Falkenstein, M., Hoormann, J., Christ, S. & Hohnsbein, J. 2000. ERP components on reaction 
errors and their functional significance: a tutorial. Biological Psychology, 51, 87-107. 
Filbey, F. & Yezhuvath, U. 2013. Functional connectivity in inhibitory control networks and 
severity of cannabis use disorder. The American Journal of Drug and Alcohol Abuse, 
39, 382-391. 
Goldstein, R. Z. & Volkow, N. D. 2002. Drug addiction and its underlying neurobiological 
basis: Neuroimaging evidence for the involvement of the frontal cortex. American 
Journal of Psychiatry, 159, 1642-1652. 
Grant, J. E., Chamberlain, S. R., Schreiber, L. & Odlaug, B. L. 2012. Neuropsychological 
deficits associated with cannabis use in young adults. Drug and Alcohol Dependence, 
121, 159-162. 
Hester, R., Lubman, D. I. & Yücel, M. 2010. The role of executive control in human drug 
addiction. In: SELF, D. W. & STALEY GOTTSCHALK, J. K. (eds.) Behavioral 
Neuroscience of Drug Addiction. Springer Berlin Heidelberg. 
Hester, R., Nestor, L. & Garavan, H. 2009. Impaired error awareness and anterior cingulate 
cortex hypoactivity in chronic cannabis users. Neuropsychopharmacology, 34, 2450-
2458. 
Hirano, K., Imbens, G. & Ridder, G. 2003. Efficient estimation of average treatment effects 
using the estimated propensity score. Econometrica, 71, 1161-1189. 
Huddy, V. C., Clark, L., Harrison, I., Ron, M. A., Moutoussis, M., Barnes, T. R. E. & Joyce, E. 
M. 2013. Reflection impulsivity and response inhibition in first-episode psychosis: 
relationship to cannabis use. Psychological Medicine, 43, 2097-2107. 
Imbens, G. W. 2004. Nonparametric estimation of average treatment effects under 
exogeneity: A review. Review of Economics and Statistics, 86, 4-29. 
Jutras-Aswad, D., Jacobs, M. M., Yiannoulos, G., Roussos, P., Bitsios, P., Nomura, Y., Liu, X. 
& Hurd, Y. L. 2012. Cannabis-dependence risk relates to synergism between 
Neuroticism and proenkephalin SNPs associated with amygdala gene expression: 
Case-control study. PLoS ONE, 7, e39243. 
Kok, A., Ramautar, J. R., De Ruiter, M. B., Band, G. P. H. & Ridderinkhof, K. R. 2004. ERP 
components associated with successful and unsuccessful stopping in a stop-signal 
task. Psychophysiology, 41, 9-20. 
Kowal, M. A., van Steenbergen, H., Colzato, L. S., Hazekamp, A., van der Wee, N. J. A., 
Manai, M., Durieux, J. & Hommel, B. 2015. Dose-dependent effects of cannabis on 
15 
the neural correlates of error monitoring in frequent cannabis users. European 
Neuropsychopharmacology, 25, 1943-1953. 
Logan, G. D. 1994. On the ability to inhibit thought and action: A users' guide to the stop 
signal paradigm. In: DAGENBACH, D. & CARR, T. H. (eds.) Inhibitory processes in 
attention, memory and language. San Diego, California: Academic Press. 
Logan, G. D., Cowan, W. B. & David, K. A. 1984. On the ability to inhibit simple and choice 
reaction time responses: a model and a method. Journal of Experimental Psychology: 
Human Perception and Performance, 10, 276-291. 
Lovell, M. E., Bruno, R., Johnston, J., Matthews, A., McGregor, I., Allsop, D. J. & Lintzeris, N. 
2018. Cognitive, physical, and mental health outcomes between long-term cannabis 
and tobacco users. Addictive Behaviors, 79, 178-188. 
Luijten, M., Kleinjan, M. & Franken, I. H. 2016. Event-related potentials reflecting smoking cue 
reactivity and cognitive control as predictors of smoking relapse and resumption. 
Psychopharmacology, 233, 2857-2868. 
Mahmood, O. M., Goldenberg, D., Thayer, R., Migliorini, R., Simmons, A. N. & Tapert, S. F. 
2013. Adolescents' fMRI activation to a response inhibition task predicts future 
substance use. Addictive Behaviors, 38, 1435-1441. 
Maij, D. L., Wetering, B. J. v. d. & Franken, I. H. 2017. Cognitive control in young adults with 
cannabis use disorder: An event-related brain potential study. Journal of 
Psychopharmacology, 31, 1015-1026. 
McCaffrey, D. F., Ridgeway, G. & Morral, A. R. 2004. Propensity score estimation with 
boosted regression for evaluating causal effects in observational studies. 
Psychological Methods, 9, 403-425. 
Moreno, M., Estevez, A. F., Zaldivar, F., Montes, J. M. G., Gutiérrez-Ferre, V. E., Esteban, L., 
Sánchez-Santed, F. & Flores, P. 2012. Impulsivity differences in recreational 
cannabis users and binge drinkers in a university population. Drug and Alcohol 
Dependence, 124, 355-362. 
National Health and Medical Research Council, 2009. Australian guidelines to reduce health 
risks from drinking alcohol. Canberra. 
Nicholls, C., Bruno, R. & Matthews, A. 2015. Chronic cannabis use and ERP correlates of 
visual selective attention during the performance of a flanker go/nogo task. Biological 
Psychology, 110, 115-125. 
Nieuwenhuis, S., Ridderinkhof, K. R., Blom, J., Band, G. P. H. & Kok, A. 2001. Error-related 
brain potentials are differentially related to awareness of response errors: Evidence 
from an antisaccade task. Psychophysiology, 38, 752-760. 
Nieuwenhuis, S., Yeung, N., van den Wildenberg, W. & Ridderinkhof, K. R. 2003. 
Electrophysiological correlates of anterior cingulate function in a go/no-go task: 
Effects of response conflict and trial type frequency. Cognitive, Affective, & 
Behavioral Neuroscience, 3, 17-26. 
Norman, A. L., Pulido, C., Squeglia, L. M., Spadoni, A. D., Paulus, M. P. & Tapert, S. F. 2011. 
Neural activation during inhibition predicts initiation of substance use in adolescence. 
Drug and Alcohol Dependence, 119, 216-223. 
Picton, T. W., Bentin, S., Berg, P., Donchin, E., Hillyard, S. A., Johnson, R., Miller, G. A., 
Ritter, W., Ruchkin, D. S., Rugg, M. D. & Taylor, M. J. 2000. Guidelines for using 
human event-related potentials to study cognition: Recording standards and 
publication criteria. Psychophysiology, 37, 127-152. 
Pope, H. G., Gruber, A. J., Hudson, J. I., Huestis, M. A. & Yurgelun-Todd, D. 2001. 
Neuropsychological performance in long-term cannabis users. Archives of General 
Psychiatry, 58, 909-915. 
Quednow, B., Kühn, K.-U., Hoppe, C., Westheide, J., Maier, W., Daum, I. & Wagner, M. 2007. 
Elevated impulsivity and impaired decision-making cognition in heavy users of MDMA 
("Ecstasy"). Psychopharmacology, 189, 517-530. 
R Development Core Team, 2017. R: A language and environment for statistical computing. 
Vienna, Austria: R Foundation for Statistical Computing. 
Ramaekers, J., Kauert, G., Theunissen, E., Toennes, S. & Moeller, M. 2009. Neurocognitive 
performance during acute THC intoxication in heavy and occasional cannabis users. 
Journal of Psychopharmacology, 23, 266-277. 
Rasmussen, J., Casey, B. J., van Erp, T. G., Tamm, L., Epstein, J. N., Buss, C., Bjork, J. M., 
Molina, B. S., Velanova, K., Mathalon, D. H., Somerville, L., Swanson, J. M., Wigal, 
16 
T., Arnold, L. E. & Potkin, S. G. 2016. ADHD and cannabis use in young adults 
examined using fMRI of a Go/NoGo task. Brain Imaging Behav, 10, 761-71. 
Ridgeway, G., McCaffrey, D. F. & Morral, A. R. 2010. Twang: Toolkit for weighting and 
analysis of nonequivalent groups. Version 1.2-2 ed. 
Saunders, J. B., Aasland, O. G., Babor, T. F., De La Fuente, J. R. & Grant, M. 1993. 
Development of the Alcohol Use Disorders Identification Test (AUDIT): WHO 
Collaborative Project on early detection of persons with harmful alcohol consumption-
II. Addiction, 88, 791-804. 
Semlitsch, H. V., Anderer, P., Schuster, P. & Presslich, O. 1986. A solution for reliable and 
valid reduction of ocular artifact, applied to the P300 ERP. Psychophysiology, 23, 
695-703. 
Simons, R. F. 2010. The way of our errors: Theme and variations. Psychophysiology, 47, 1-
14. 
Skinner, H. A. 1977. Lifetime Drinking History Structured Interview., Toronto, Ontario, 
Canada, Author. 
Smith, J. L., Iredale, J. M. & Mattick, R. P. 2016. Sex differences in the relationship between 
heavy alcohol use, inhibition and performance monitoring: disconnect between 
behavioural and brain functional measures. Psychiatry Research: Neuroimaging, 254, 
103-111. 
Smith, J. L., Mattick, R. P., Jamadar, S. & Iredale, J. M. 2014. Deficits in behavioural inhibition 
in substance abuse and addiction: A meta-analysis. Drug and Alcohol Dependence, 
145, 1-33. 
Takagi, M., Lubman, D. I., Cotton, S., Fornito, A., Baliz, Y., Tucker, A. & Yücel, M. 2011. 
Executive control among adolescent inhalant and cannabis users. Drug and Alcohol 
Review, 30, 629-637. 
Tamm, L., Epstein, J. N., Lisdahl, K. M., Molina, B., Tapert, S., Hinshaw, S. P., Arnold, L. E., 
Velanova, K., Abikoff, H. & Swanson, J. M. 2013. Impact of ADHD and cannabis use 
on executive functioning in young adults. Drug and Alcohol Dependence, 133, 607-
614. 
Tannock, R., Schachar, R. & Logan, G. 1995. Methylphenidate and cognitive flexibility: 
Dissociated dose effects in hyperactive children. Journal of Abnormal Child 
Psychology, 23, 235-266. 
Tapert, S. F., Schweinsburg, A. D., Drummong, S. P. A., Paulus, M. P., Brown, S. A., Yang, 
T. T. & Frank, L. R. 2007. Functional MRI of inhibitory processing in abstinent 
adolescent marijuana users. Psychopharmacology, 194, 173-184. 
Tarter, R. E., Kirisci, L., Mezzich, A., Cornelius, J. R., Pajer, K., Vanyukov, M., Gardner, W., 
Blackson, T. & Clark, D. B. 2003. Neurobehavioral disinhibition in childhood predicts 
early age at onset of substance use disorder. American Journal of Psychiatry, 160, 
1078-1085. 
Theunissen, E. L., Kauert, G. F., Toennes, S. W., Moeller, M. R., Sambeth, A., Blanchard, M. 
M. & Ramaekers, J. G. 2012. Neurophysiological functioning of occasional and heavy 
cannabis users during THC intoxication. Psychopharmacology, 220, 341-350. 
van den Wildenberg, W. P. M., van der Molen, M. W. & Logan, G. D. 2002. Reduced 
response readiness delays stop signal inhibition. Acta Psychologica, 111, 155-160. 
Wright, L., Lipszyc, J., Dupuis, A., Thayapararajah, S. W. & Schachar, R. 2014. Response 
Inhibition and Psychopathology: A Meta-Analysis of Go/No-Go Task Performance. 
Journal of Abnormal Psychology, 123, 429-439. 
 
 
  
17 
ACKNOWLEDGEMENTS 
This study was funded by a UNSW Vice-Chancellor’s Postdoctoral Fellowship to Dr Smith. 
The National Drug and Alcohol Research Centre at the University of New South Wales is 
supported by funding from the Australian Government under the Substance Misuse 
Prevention and Service Improvements Grants Fund. 
 
Thanks are due to Mr Tony Kemp for writing the stimulus presentation program. 
 
 
